Navigation Links
Consumer Groups Will Continue to Press Stem Cell Patent Challenge
Date:2/28/2008

SANTA MONICA, Calif., Feb. 28 /PRNewswire-USNewswire/ -- Two consumer groups said today that they will continue their challenge of three overreaching patents on human stem cells held by the Wisconsin Alumni Research Foundation (WARF) despite a non-final decision by Patent Office allowing three amended claims in one of the disputed patents.

The Foundation For Taxpayer and Consumer Rights (FTCR) and the Public Patent Foundation (PUBPAT) said they would appeal any later final decision by the examiner supporting the claims to the Patent and Trademark Office's Board of Appeals, which frequently overturns the decision made by examiners. The groups also have the right to appeal any decision of that board to the U.S. Circuit Court for the Federal Circuit, if necessary.

The "non-final office decision" in the inter partes re-examination of the '913 patent was posted late Wednesday on the PTO's website.

"We won the first round when the PTO rejected all claims of the '780, '806 and '913 patents," said John M. Simpson, FTCR Stem Cell Project Director. "Now WARF has won the second round with respect to just one of the patents, but the battle is hardly over. We're in this for the long haul."

"The examiner based his decision on his own belief that it would not have been obvious to isolate human stem cells using widely known methods to isolate mouse stem cells, which contradicts the sworn testimony that we provided of four renowned stem cell embryologists who were doing such work", said Dan Ravicher, PUBPAT Executive Director. "Thus, the examiner took his own opinion over the opinions of our four leading stem cell scientist witnesses."

Joining the two consumer groups in the challenge from the beginning was Dr. Jeanne Loring, now of the Scripps Institute. After the initial rejection, Dr. Alan Trounson, then of Australia's Monash University and now president of the California Institute for Regenerative Medicine, Dr. Douglas Melton of Harvard and Dr. Chad Cowan of Harvard filed affidavits supporting the challenge.

The two groups noted that the patent challenge has already improved the situation for stem cell researchers; shortly after the PTO announced it would re-examine the three patents, WARF announced a substantial easing of its licensing requirements.

"WARF executives were acting like arrogant bullies blinded by dollar signs," said Simpson. "Our challenge has engendered a more co-operative stance on their part."

Decisions are pending on the other two patents. No other country recognizes the three WARF patents.

The Foundation for Taxpayer and Consumer Rights is California's leading non-profit and non-partisan consumer watchdog group. For more information visit us on the web at: http://www.ConsumerWatchdog.org.

The Public Patent Foundation is a not-for-profit legal services organization that represents the public's interests against the harms caused by the patent system, particularly the harms caused by wrongly issued patents and unsound patent policy. For more information, visit us on the web at http://www.pubpat.org.


'/>"/>
SOURCE Foundation for Taxpayer and Consumer Rights
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Eyes on Puerto Rico: Johnson & Johnson Markets New Contact Lenses Directly to Consumers
2. Health and Fashion - Dow Corning Predicts the Top Trends Driving Consumers to the Beauty Counters
3. Weight Watchers to Present at Bank of America 2008 Consumer Conference
4. Kryptiq and Microsoft to Showcase Unprecedented Connectivity Between Consumers and Their Doctors at HIMSS 08
5. Microsoft to Showcase Innovative Solutions for Healthcare Providers and Consumers at HIMSS 2008 Annual Conference & Exhibition
6. Consumer Group Welcomes Introduction of Stem Cell Agency Oversight Bill
7. Men Are Vein Too: Innovative Treatment Sparks Unexpected Consumer Trend
8. Clarity for Consumers on Botox Complication and Death Reports
9. IHF Says Google Personal Health-Records System Gives Consumers Greater Control Over Privacy than HIPAA Rules
10. Groundbreaking Deloitte Survey Reveals Many U.S. Consumers Want Major Changes in Health Care Design, Delivery
11. Wyeth Consumer Healthcare Names New Head of Global R&D
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... 2016 , ... Fertility Centers of New England announced today the opening of ... Center provides convenient access to care for patients seeking fertility treatment in Maine. “We ... Comprehensive Care in Portland,” said Fertility Centers of New England President and CEO, Joseph ...
(Date:5/4/2016)... ... 2016 , ... Vasont Systems, a top component content management ... the latest release of Adobe FrameMaker, Release 2015. The integration of the Vasont® ... editing and storing XML. , The VUI creates a smooth continued ...
(Date:5/3/2016)... Minnesota (PRWEB) , ... May 04, 2016 , ... ... more than 40 national and global construction firms representing the Construction Industry Safety ... have joined forces with one purpose: to inspire everyone in the industry to ...
(Date:5/3/2016)... Garden City, NY (PRWEB) , ... May 04, 2016 , ... ... as a 2016-2017 inductee into its VIP Woman of the Year Circle. She ... leading networking organization exclusively for professional women, boasting more than 850,000 members and over ...
(Date:5/3/2016)... CA (PRWEB) , ... May 03, 2016 , ... ... on Denver Business Journal, patients report dissatisfaction with numerous issues related to medical ... personnel, issues with billing, and poor bedside manner from hospital staff. Commenting on ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 4, 2016 ... 154 pages, profiling 09 key companies and supported ... professional and in-depth study on the current state ... overview of the industry including definitions, classifications, applications ... analysis is provided for the international market including ...
(Date:5/3/2016)... , May 4, 2016 ... "Global Cancer Stem Cell Therapy Market Outlook 2020" ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,Recombinant technology has improved ... are expected to be developed in coming years. Many ... techniques. Cancer stem cell therapies are also expected to ...
(Date:5/3/2016)... , May 3, 2016  As a teenager, ... contracted rheumatic fever, which damaged his heart. He continued ... But by June 2013, Shepherd,s heart was giving out ... death. On June 20, 2013, the Mesa, ... Artificial Heart (TAH-t). Like a heart transplant, the SynCardia ...
Breaking Medicine Technology: